Background: Adnexal components tumors of the skin are very rare and are seen as benign lesions of the scalp in aged women. Trichilemmal tumor is usually benign and rarely under goes malignant transformation in a stepwise manner starting with an adenomatous stage of the trichilemmal cyst to an epitheliomatous stage of the proliferating trichilemmal tumor (PTT) evolving into the carcinomatous stage of the malignant proliferating trichilemmal tumor (MPTT). Case report: A 53yearold woman reported with huge swelling in the posterior region of the scalp. The swelling was mobile and soft to firm in consistency not fixed to the skull bone. The surface was smooth and getting under the swelling was not possible, needle biopsy reported as trichilemmal tumor. Contrast enhanced computed tomography (CECT) neck did not show any nodes in the neck, especially the posterior compartment. The tumor was widely excised with 1 cm margin and the periosteum was kept intact with split skin graft. An area of periosteal adher ence to the tumor seen was excised. The histopathology report on serial sectioning reported grade 1 moderately differentiated squamous cell carcinoma (SCC). Postoperative external beam radiotherapy of 66 Gy was given. The patient is being followed up and no recurrence is seen. Conclusion: Malignant transformation in a proliferating trichilemmal tumor a rare entity and should be differentiated from SCC and the better prognostic trichilemmal carcinoma. A protocolbased adjuvant therapy is available for squamous cell carcinoma but not for trichilemmal carcinoma (TLC) and MPTT. A major metaanalysis may help to establish a clinical outcome based classification and management protocol for these tumors.
INTRoduCTIoN
Malignant proliferating trichilemmal tumor (MPTT) is a rare neoplasm arising from the external root sheath of the hair follicle seen in women over the 6th decade. [1] [2] [3] They vary from well circumscribed to irregularly defined subcutaneous nodules with squamoid cytologic features and trichilemmal-type of keratinization with cystic to firm in consistency. 2, 4 This initially described with confusing histologic features of squamous cell carcinoma (SCC). 5 The tumor is also called epidermoid cyst, pilar tumor of the scalp, proliferating trichilemmal cyst, proliferating epidermoid cyst, giant hair matrix tumor, hydatidiform keratinous cyst, trichochlamydo carcinoma, and invasive hair matrix tumor. 6 Incidences are seen in older age females predominantly affecting the scalp and rarely eyelids, neck and face. 7, 8 While MPTT usually arises as a subepidermal tumor, the other similar tumor trichilemmal carcinoma (TLC) occurs as exophytic, popular or nodular lesion measu ring less than 2 cm. 3 This malignant lesion is seen in the sunexposed scalp, solar keratosis, scars of burns, following high-dose radiation exposure and in post-transplant states. 5 The incidence of benign is more compared to the malignant appendageal tumors, only few reports in literature with an aggressive clinical course and a propensity for nodal and distant metastases. 9 Malignant proliferating trichilemmal tumor (MPTT) is a very uncommon tumor may be seen as longstanding nodular scalp lesions and histological evidence of significant abnormal mitosis, marked cellular pleomorphism, infiltrating margins and aneuploidy reflect malignant transformation.
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We report a case of SCC masquerading as MPTT of the scalp. Initially, it appeared as a benign trichilemmal tumor, later on serial sectioning of the suspicious margins moderately differentiated SCC was confirmed.
CASe RePoRT
A 53-year-old woman reported with huge swelling in the posterior region of the scalp. It was a soft-tissue swelling 12 × 12 × 12 cm in dimensions. The swelling was mobile and soft to firm in consistency not fixed to the skull bone (Fig. 1) . The surface was smooth and getting under the swelling was not possible. Routine investigations, fine IJHNS needle aspi ration cytology (FNAC), contrast enhanced computed tomography (CECT) brain with enhanced bone window, magnetic resonance imaging (MRI) was done.
Trichilemmal tumor of skin appendages was reported. CECT neck did not show any nodes in the neck, especially the posterior compartment. The tumor was widely excised with 1 cm margin and the periosteum was kept intact. Split skin graft was harvested from the medial side of the thigh and the defect covered with it under general anesthesia (Fig. 2 ). An area of periosteal adherence to the tumor was excised. The histopathology report on serial sectioning reported grade 1 moderately differentiated SCC. Patient was planned with postoperative radiotherapy of 66 Gy in 33 fractions with electrons of 6 MeV to a depth of 2 cm prescribed to 90% isodose. The treatment area was defined as the volume of tumor with microscopic extension with a 1 cm margin. Customized cerrobend electron cut-outs were made, and the patient was treated in prone position to avoid scatter dose to critical structures and achieve uniform dose distribution. The patient was examined at the beginning of treatment and weekly thereafter till the end of treatment. She experienced grade II skin reaction at the end of therapy. The patient is being followed up and no recurrence is seen.
dISCuSSIoN
Tumors arising from the adnexal components of the skin pilosebaceous unit, eccrine or apocrine glands are very rare and display more than one line of differentiation. 11 Most of the tumors are benign, but malignant varieties also exist which are very rare, locally aggressive, having potential for nodal and distant metastasis, with a poor prognosis. 11 So, hunting for features of malignancy in these mostly benign tumors seems challenging as the incidences are very low.
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Adnexal components tumors of the skin are very rare and are seen as benign lesions of the scalp in aged women. 12, 13 The benign includes trichofolliculoma, desmoplastic trichoepithelioma, trichoblastoma, trichoblastic fibroma, trichoadenoma, proliferating trichilemmal tumor, trichilemmoma, desmoplastic trichilemmoma, pilomatricoma, sebaceous adenoma and sebaceous epithelioma. 12, 13 The malignant includes TLC, trichoblastic carcinoma, MPTT, pilomatrix carcinoma, sebaceous carcinoma, basal cell carcinoma with sebaceous differentiation.
They are not seen in the alopecic individuals, as lanugo hair follicles of the bald scalp and follicles of other areas devoid of non-terminal hair are unlikely to produce these tumors. 9 They are seen in areas of excess hair growth arising through increased epithelial proliferation within pilar or sebaceous cysts. 9 The tumor may be of a long standing cyst like lesion on the scalp which has to be differentiated from well-differentiated carcinoma.
14 Trichilemmal tumor is usually benign and rarely may undergo malignant transformation in a stepwise manner starting with an adenomatous stage of the trichilemmal cyst to an epitheliomatous stage of the PTT evolving into the carcinomatous stage of the MPTT.
5
Malignant and benign tumors can be differentiated on the basis of morphological criteria, i.e. rate of growth, invasion and metastasis and functional criteria, i.e. anaplasia and cellular atypia. 15 Clear cells appearing from the outer root sheath of hair exhibiting marked pleomorphism and atypical mitosis, with nodular trabecular formation of keratinocytes with a sharp border bet ween parenchyma and stroma confirms the trichilemmal tumor. 13 The rare malignant change has a circumscribed nodular or a diffuse spindle cell type which has to differentiated from metastases of spindle cell tumors with regions of squamous differentiation. 1 MPTT has trichilemmal keratinization, lobular pattern and the lack of a precursor epidermal lesion such an actinic keratosis while SCC has fields of keratin production. 16 MPTT metastasize and recurs more frequently than SCC and resembles TLC on histology. 16 A trichilemmal tumor has to be differentiated from sebaceous carcinoma, clear cell hidradenocarcinoma, cutaneous metastasis of renal cell carcinomas, MPTT, TLC and SCC. 6, 14 Trichilemmal carcinoma usually shows continuity with the epidermis or follicular epithelium as a pagetoid interface and exhibits trichilemmal keratinization and dermal invasion. 17 Ye et al categorized these tumors on histopathological characteristics and invasiveness. 4 Group I had no infiltration of surrounding stroma and minimal nuclear atypia; they showed trichilemmal keratinization, stromal invasion with a mononuclear infiltrate of plasma cells and lymphocytes, and dystrophic calcification and were considered as benign tumors. 4 Group II was early invasive, with modest cytological abnormalities, eosinophilic cytoplasm and loose edematous stroma with minimal to moderate infiltration by mononuclear inflammatory cells; they were considered locally aggressive. 4 Group III tumors were invasive; they were cytologically anaplastic and were, therefore, considered malignant. Statistically, significant difference in terms of local control and lymph node metastatic potential was found between the groups. 4 Malignant proliferating trichilemmal tumor on gross pathology shows solid, lobular and trabecular areas with periodic acid schiff (PAS) stain-positive hyaline membrane. 18 Large oval to polygonal tumor cells with moderate cytological atypia with focal areas of pilar type of keratinization with peripheral palisading of cells.
9
Infiltration into the dermis, features of necrosis, calcification with individual cell keratinisation and mitotic figures are seen. 9 As the malignant changes are very rare in trichilemmal tumor, metastasis are hardly documented and may be seen as sudden rapid growth. 15, 19 The classification is a histopathological and not clinical and so a composite classification based on both features are essential for accurate management. 15, 19 All MPTT expresses immunostaining to cytokeratin 5 and 6, while the normal immunoreactivity pattern for CD 34 noticed in tumors of outer root sheath is lost due to undifferentiation. 20, 21 A heterogenous enhanced mass with poorly-defined margins is seen on MRI.
18
A meta-analysis on aggressive variant, the MPTT was done which confirmed it to be aggressive and has tendency to recur and metastasize distantly. 22 Here, adjuvant therapy was not used and the outcome was variable, which led for a possible role of adjuvant radio therapy or chemotherapy to improve disease-free survival. 6 Ye et al reported 50% recurrence in MPTT within 2 to 14 months where none had been given adjuvant therapy. 4 Trichilemmal carcinoma (TLC) is treated with wide local excision as the lesion is slow growing with no reported incidences of recurrence or metastasis. 23 MPTT needs a wide local excision with a 1 cm margin of normal tissue with regular follow-up. 23 Role of adjuvant radiation and chemotherapy in MPTT is suggested as the tumor has high rates of locoregional recurrence and distant failures due to its aggressive nature. 1 As the incidences are low, the added advantage of adjuvant therapy is not established. 1 However, in view of the malignant squamous cell component of the tumor, we considered it prudent to irradiate the patient. 24 The various modalities of radiotherapy practised for skin tumors include superficial x-ray, electrons, photons, brachytherapy or a combination of any of the above. 25 Since electrons have been established as equivalent to superficial x-ray, we chose electron beam therapy as it was easily available at our institute. 26, 27 Unlike head and neck SCC which are locoregional, pilar tumors are primarily local only and managed with wide local excision. 1 The tumor may present as a large fungated mass and the presence of multiple histopathologically-proven metastatic nodes with perinodal extension and may need wide excision and adjuvant therapy. 1 An accurate analysis of the histopathology is necessary as MPTT is a rare variant and more studies are required to place adjuvant therapy as a protocol for these tumors. 1 Mann et al reported metastasis from trichilemmal tumors, while Seff and Berkowitz reported cer-vical metastasis from MPTT and dissemination.
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CoNCluSIoN
Malignant transformation in a proliferating trichile mmal tumor a rare entity and should be differentiated from squamous cell carcinoma and the better prognostic trichilemmal carcinoma. A protocol-based adjuvant therapy is available for SCC but not for TLC and MPTT. A major meta-analysis may help to establish a clinical outcome-based classification and management protocol for these tumors.
